Research Progress of Traditional Chinese Medicine Regulating PI3K/AKT/mTOR Signaling Pathway to Improve Myocardial Ischemia-Reperfusion Injury

© 2025 by the Authors. Licensee Whioce Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )

Download PDF

Cite

XML

HTML

Abstract

PI3K/AKT/mTOR signaling pathway is a key pathway of myocardial ischemia-reperfusion injury (MIRI). The mechanism of action is mainly oxidative stress, inflammatory response, calcium overload, ferroptosis, autophagy, and apoptosis. MIRI belongs to the category of chest obstruction in traditional Chinese medicine, and its etiology and pathogenesis are mainly “Yang Wei Yin Xian.” Traditional Chinese medicine has the effect of multi-target and multi-component effect, and has played a significant role in the treatment of MIRI in recent years. At present, the monomers of traditional Chinese medicine mainly include saponins, flavonoids, alkaloids, terpenoids, and phenols, and the compounds mainly include Zhigancao Decoction, Zhenyuan Capsule, Jiawei Shenqibai Powder, Qili Qiangxin Capsule, Tongmai Yangxin Pill, Zhilong Huoxue Tongyu Capsule, Guizhi Tongluo Tablets, etc. This paper reviews the research on the improvement of MIRI by regulating PI3K/ AKT/mTOR signaling pathway in recent years, and expounds the mechanism and advantages of traditional Chinese medicine in the treatment of MIRI.

References

Levine GN, Bates ER, Blankenship JC, et al., 2011, American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Society for Cardiovascular Angiography and Interventions.2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol, 58(24): e44–122.

Frank A, Bonney M, Bonney S, et al., 2012, Myocardial Ischemia Reperfusion Injury: From Basic Science to Clinical Bedside. Semin Cardiothorac Vasc Anesth, 16(3): 123–132.

Huang J, Chen L, Wu J, et al., 2022, Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions. J Med Chem, 65(24): 16033–16061.

Tian Y, 2012, Initial Exploration of the Meaning of “Yang Micro and Yin String” in the Differential Treatment of Chest Bi Syndrome. Liaoning Journal of Traditional Chinese Medicine, 39(3): 451–452.

Hu N, Wang B, 2016, Discussion on the Treatment of Chest Bi and Heartache from the Perspective of “Yang Micro and Yin String.” Zhejiang Journal of Traditional Chinese Medicine, 51(5): 374.

Chen B, Pan Z, Su X, et al., 2007, Study on the Changes of TCM Syndrome Types Before and After Interventional Therapy for Coronary Heart Disease. Chinese Journal of Integrated Traditional and Western Medicine, (08): 689–691.

Wang X, Zhang S, Shu H, et al., 2016, Examples of Professor Chen Xinyu’s Theory Application of “Yang Micro and Yin String Means Chest Bi and Pain.” Chinese Journal of Emergency in Traditional Chinese Medicine, 25(5): 819–820 + 838.

Han J, 2019, Scientific Connotation of Heart Qi Deficiency and Blood Stasis and the Mechanism of Qi Shen Yi Qi Dropping Pills in Tonifying Qi and Activating Blood. World Science and Technology—Modernization of Traditional Chinese Medicine, 21(02): 139–147.

Chen C, Dong B, 2019, Analysis of the Etiology and Pathogenesis of Myocardial Ischemia-Reperfusion Injury from the Perspective of Jueyin Disease in Traditional Chinese Medicine. Journal of Integrated Traditional Chinese and Western Medicine in Cardiovascular and Cerebrovascular Diseases, (5): 783–785.

Sarris EG, Saif MW, Syrigos KN, 2012, The Biological Role of PI3K Pathway in Lung Cancer. Pharmaceuticals (Basel), 5(11): 1236–1264.

Xue JF, Shi ZM, Zou J, et al., 2017, Inhibition of PI3K / AKT / mTOR Signaling Pathway Promotes Autophagy of Articular Chondrocytes and Attenuates Inflammatory Response in Rats with Osteoarthritis. Biomed Pharmacother, 89: 1252–1261.

Wullschleger S, Loewith R, Hall MN, 2006, TOR Signaling in Growth and Metabolism. Cell, 124(3): 471–484.

Pattingre S, Espert L, Biard-Piechaczyk M, et al., 2008, Regulation of Macroautophagy by mTOR and Beclin 1 Complexes. Biochimie, 90(2): 313–323.

Ghomlaghi M, Yang G, Shin SY, et al., 2021, Dynamic Modelling of the PI3K/mTOR Signalling Network Uncovers Biphasic Dependence of mTORC1 Activity on the mTORC2 Subunit SIN1. PLoS Comput Biol, 17(9): e1008513.

Li M, Wang H, 2018, Research Progress on the Anti-atherosclerotic Effect of Emodin in Processed Polygonum Multiflorum. Journal of Practical Traditional Chinese Medicine, 34(8): 1012–1014.

Goncharov RG, Sharapov MG, 2023, Ischemia-reperfusion Injury: Molecular Mechanisms of Pathogenesis and Methods of Their Correction. Mol Biol, 57(6): 1143.

Heusch G, Andreadou I, Bell R, et al., 2023, Health Position Paper and Redox Perspectives on Reactive Oxygen Species as Signals and Targets of Cardioprotection. Redox Biol, 67: 102894.

Lee MCI, Velayutham M, Komatsu T, et al., 2014, Measurement and Characterization of Superoxide Generation from Xanthine Dehydrogenase: A Redox-regulated Pathway of Radical Generation in Ischemic Tissues. Biochemistry, 53(41): 6615.

Ma MW, Wang J, Zhang Q, et al., 2017, NADPH Oxidase in Brain Injury and Neurodegenerative Disorders. MolNeurodegener, 12(1): 7.

Kurian GA, Rajagopal R, Vedantham S, et al., 2016, The Role of Oxidative Stress in Myocardial Ischemia and Reperfusion Injury and Remodeling: Revisited. Oxid Med Cell Longev, 2016: 1656450.

Hoxhaj G, Manning BD, 2020, The PI3K-AKT Network at the Interface of Oncogenic Signalling and Cancer Metabolism. Nat Rev Cancer, 20(2): 74–88.

Xu X, Liang T, Lin X, et al., 2015, Effect of the Total Extract of Averrhoacarambola (Oxalidaceae) Root on the Expression Levels of TLR4 and NF-κB in Streptozotocin-Induced Diabetic Mice. Cell Physiol Biochem, 36(6): 2307–2316.

Stark AK, Sriskantharajah S, Hessel EM, et al., 2015, PI3K Inhibitors in Inflammation, Autoimmunity and Cancer. Curr Opin Pharmacol, 23: 82–91.

Ye J, Wang R, Wang M, et al., 2021, Hydroxysafflor Yellow A Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Calcium Overload and Apoptosis. Oxid Med Cell Longev, 2021: 6643615.

Murphy E, Steenbergen C, 2008, Mechanisms Underlying Acute Protection from Cardiac Ischemia-reperfusion Injury. Physiol Rev, 88(2): 581–609.

Dixon SJ, Lemberg KM, Lamprecht MR, et al., 2012, Ferroptosis: An Iron-dependent Form of Nonapoptotic Cell Death. Cell, 149(5): 1060–1072.

Wang L, Wang Z, Yu L, et al., 2022, Research Progress on Iron Metabolism and Iron Homeostasis Imbalance. Journal of Public Health and Preventive Medicine, 33(3): 118–122.

Tang D, Chen X, Kang R, et al., 2021, Ferroptosis: Molecular Mechanisms and Health Implications. Cell Research, 31(2): 107–125.

Zou C, Chen C, Wang F, et al., 2021, Research Progress on Autophagy Modulators based on the PI3K/Akt/mTOR Signaling Pathway. Chinese Journal of Medicinal Chemistry, 31(10): 825–833.

Jia M, Qiu H, Lin L, et al., 2022, Inhibition of the PI3K/AKT/mTOR Signaling Pathway Activates Autophagy and Suppresses Peritoneal Fibrosis in the Process of Peritoneal Dialysis. Frontiers in Physiology, 13: 778479.

Zheng W, Zhan Z, Wu Z, et al., 2023, Alprostadil Regulates the PI3K/AKT/mTOR Pathway to Inhibit Autophagy Induced by Myocardial Ischemia-reperfusion Injury. Chinese Journal of Gerontology, 43(13): 3280–3285.

Yao M, Zhang J, Li Z, et al., 2021, Liraglutide Protects Nucleus Pulposus Cells Against High-Glucose Induced Apoptosis by Activating PI3K/Akt/mTOR/Caspase-3 and PI3K/Akt/GSK3beta/Caspase-3 Signaling Pathways. Front Med (Lausanne), 8: 630962.

Li J, Guo Z, Xu J, et al., 2022, Research Progress on the Dose-effect Relationship of Traditional Chinese Medicine Intervention in Myocardial Ischemia-reperfusion Injury. Chinese Archives of Traditional Chinese Medicine, 40(10): 8–11.

Li X, Yu H, Wang S, et al., 2025, Research Progress on the Treatment of Myocardial Ischemia-reperfusion Injury by Regulating the PI3K/AKT/mTOR Signaling Pathway with Monomeric Components of Traditional Chinese Medicine. Journal of Liaoning University of Traditional Chinese Medicine, 27(04): 203–208.

Gui C, Xu L, Ma N, 2025, Ginsenoside Rg5 Inhibits the Growth of Acute Leukemia Cells by Regulating the PI3K Signaling Pathway. Journal of Qiqihar University of Medicine, 46(04): 317–320.

Yin S, Gao Y, Dai H, et al., 2025, Study on the Inhibitory Effect of Astragaloside II on the Proliferation, Invasion, and Metastasis of Triple-negative Breast Cancer Cells. Journal of Taizhou Vocational and Technical College, 25(01): 63–66 + 96.

Xu J, Pan K, Liu F, 2017, Research Progress on the Pharmacodynamics of Total Flavonoids from Bidens Bipinnata. Journal of Traditional Chinese Medicine, 32(4): 610–612.

Dong F, Han L, 2023, Effects of Total Flavonoids from Bidens Bipinnata on Myocardial Fibrosis in Hypertensive Rats by Regulating the PI3K/Akt/mTOR Autophagy Pathway. Guangdong Medical Journal, 44(06): 720–728.

Chen J, Lee M, Wang C, et al., 2017, Autophagic Effects of Hibiscus Sabdariffa Leaf Polyphenolsand Epicatechin Gallate (ECG) Against Oxidized LDL-induced Injury of Humanendothelial Cells. European Journal of Nutrition, 56(5): 1963–1981.

Ma X, 2023, Study on the Mechanism of Action of Total Flavonoids from Aromatic Ziziphora Improving AS by Regulating the PI3K/Akt/mTOR Pathway, dissertation, Shihezi University.

Sun D, Niu Z, Zhang S, et al., 2023, Exploring the Effect and Mechanism of Total Alkaloids from Strychnos Nux-vomica on Rats with Rheumatoid Arthritis based on the PI3K/Akt/mTOR Pathway. Modern Chinese Medicine, 25(12): 2521–2527.

Li J, Wu J, Huang J, et al., 2022, Uncovering the Effect and Mechanism of Rhizoma Corydalis on Myocardial Infarction Through an Integrated Network Pharmacology Approach and Experimental Verification. Front Pharmacol, 13: 927488.

Wu J, Chen S, Wu P, et al., 2022, Cathepsin B/HSP70 Complex Induced by Ilexsaponin I Suppresses NLRP3 Inflammasome Activation in Myocardial Ischemia/reperfusion Injury. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 105: 154358.

Feng M, Xu H, He H, et al., 2019, Total Triterpenes from Chaenomeles Speciosa induce Apoptosis in Gastric Cancer Cells by Regulating miR-10a and the PI3K/Akt/mTOR/p70S6K Signaling Pathway. Chinese Medicinal Materials, 42(12): 2929–2935.

Zhang M, Shen Y, 2022, Research Progress on the Cardiovascular Pharmacological Effects of Magnolol. Anti-Infection Pharmacy, 19(10): 1395–1400.

Du B, Lu M, Sui H, et al., 2025, Magnolol Regulates the TLR4/PI3K/Akt/mTOR Signaling Pathway and Autophagy to Improve Lipopolysaccharide-induced Myocardial Injury. Chinese Journal of Hospital Pharmacy, 45(09): 1000–1005 + 1014.

Huang J, Mao J, Gu Y, et al., 2024, Study on the Effect of Salvianolic Acid B on the Biological Function of Senescent Macrophages through the PI3K/AKT/mTOR Signaling Pathway. New Chinese Medicine, 56(12): 197–203.

Wang F, 2024, Salvianolic Acid B Reverses High Glucose-induced Senescence of Human Adipose-derived Mesenchymal Stem Cells by Inhibiting the PI3K/AKT/mTOR Signaling Pathway, dissertation, Chuanbei Medical College.

Du J, Shi K, Zhao Y, et al., 2019, Salvianolic Acid B Promotes Autophagy and Reduces Myocardial Fibrosis in Rats by Inhibiting the PI3K/AKT/mTOR Pathway. Progress in Modern Biomedicine, 19(20): 3812–3817.

Zhang ZD, Yang YJ, Liu XW, et al., 2021, The Protective Effect of Aspirin Eugenol Ester on Oxidative Stress to PC12Cells Stimulated with H2O2 through Regulating PI3K/Akt Signal Pathway. Oxid Med Cell Longev, 2021: 5527475.

Qiao D, Zhou Y, 2017, Clinical Application of Zhi Gan Cao Tang in Cardiovascular Diseases. Journal of Emergency in Traditional Chinese Medicine, 26(10): 1775–1776.

Zheng X, Ma C, Chen Y, et al., 2020, Exploring the Mechanism of Zhi Gan Cao Tang’s Effect on Ventricular Tachycardia and Ventricular Fibrillation Caused by MIRI in Rats Based on the PI3K/Akt/mTOR Signaling Pathway. Chinese Journal of Experimental Traditional Medical Formulae, 26(17): 1–8.

Sun M, 2020, Zhenyuan Capsule Protects Rat Myocardial Ischemia-Reperfusion Injury by Regulating Autophagy via the PI3K/Akt/mTOR Signaling Pathway, dissertation, Jilin University.

Xu J, Liu J, Chen L, et al., 2024, Modified Shenqi Posan Protects Ischemic Myocardium in Rats with Acute Myocardial Infarction Combined with Psychological Stress by Regulating the PI3K/Akt/mTOR Signaling Pathway. Chinese Journal of Integrated Traditional and Western Medicine, 44(12): 1462–1470.

Wu N, 2024, Study on the Effect and Mechanism of Qili Qiangxin Capsule in Reducing Myocardial Ischemia-Reperfusion Injury via the PI3K/AKT/FOXO3 Signaling Pathway, dissertation, Guangzhou University of Chinese Medicine.

Pan X, Xu H, Ding Z, et al., 2024, Guizhitongluo Tablet Inhibits Atherosclerosis and Foam Cell Formation through Regulating Piezo1/NLRP3 Mediated Macrophage Pyroptosis. Phytomedicine, 132: 155827.

He X, Li S, Li Z, et al., 2025, Study on the Efficacy and Mechanism of Guizhi Tongluo Tablets in Alleviating Atherosclerosis by Inhibiting CD72hi Macrophages. China Journal of Chinese Materia Medica, 50(5): 1298.

Zhang J, Yao M, Pang S, et al., 2025, Study on the Effect and Mechanism of Guizhi Tongluo Tablets in Activating the PI3K/Akt Pathway to Reduce Cardiac Inflammation and Improve Myocardial Ischemia-reperfusion Injury in Mice. China Journal of Chinese Materia Medica, 1–9.

Pang J, Yang J, Chen S, et al., 2021, Clinical Study on the Treatment of Stable Angina Pectoris with Deficiency of Both Qi and Yin Using Tongmai Yangxin Pills. Liaoning Journal of Traditional Chinese Medicine, 48(10): 115–119.

Cai XM, Du J, Li L, et al., 2018, Clinical Metabolomics Analysis of Therapeutic Mechanism of Tongmai Yangxin Pill on Stable Angina. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 1100–1101, 106–112.

Yu L, 2024, Study on the Mechanism of Tongmai Yangxin Pills in Intervening Myocardial Ischemia/reperfusion Injury in Rats by Activating the ERα/PI3K/AKT Signaling Pathway, dissertation, Tianjin University of Traditional Chinese Medicine.

Tang R, Zhang J, Ren W, et al., 2022, Research Progress on the Prevention and Treatment of Cardiovascular Diseases with Zhilong Huoxue Tongyu Capsule. Pharmacology and Clinics of Chinese Materia Medica, 38(03): 237–240.

Zhao X, 2024, Zhilong Huoxue Tongyu Capsule Inhibits Ferroptosis of Cardiomyocytes and Reduces Ischemia-reperfusion Injury through the PI3K/AKT/Nrf2 Axis, dissertation, Southwest Medical University.

Previous article in this issue

Next article in this issue